Alder's Mab Xpress® Antibody Production System
Alder has developed a proprietary yeast expression system that has the ability to make fully functional whole antibodies at a fraction of the time and cost of other technologies. This novel system has applications both in pre-clinical and clinical stages of drug discovery.
Benefits
- Generates full-length, function-modifying antibodies at high expression levels much faster than traditional mammalian systems
- Employs a safe and reliable yeast system with a proven record in man
- Requires minimal media for improved purification and reduced cost
- Allows accelerated development cycles without cell banking, viral testing, or extensive master cell bank generation
- Uses readily available microbial manufacturing capacity for volume production
- Reduces traditional antibody production royalties
- Scales rapidly up to 50,000 Liters
- Employs technology that is easily transferable to partner facilities
Mab Xpress®
The best alternative for routinely producing quality antibody therapeutics:
Commercial Strain Development Timeline
Antibody Production Ramp Times
